151例重症药疹的临床分析(3)
[5] Farhat S，Banday M，Hassan I.Antecedent drug exposure aetiology and management protocols in Steven-Johnson Syndrome and toxic epidermal necrolysis，a hospital based pro-spective Study[J].J Clin Diagn Res，2016，10(1)：1-4.
[6] Ozeki T，Mushiroda T，Yowang A，et al.Genome-wide assoclarion study identifies HLA—A*3 101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population[J].Hum Mol Genet，20l1，20 (5)：1034-1041.
[7] Wu X T，Hu F Y，An D M，et al.Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA—B*1502 allele among patients in central China[J].Epilepsy Behav，2010，19(3)：405-408.
[8] Jarjour S，Barrete M，Normand V，et al.Genetic markers associated with cutaneous adverse drug reactions to allopurinol：a systematic review[J].Pharmacogenomics，2015，16 (7)：755-767.
[9] Yang F，Gu B，Zhang L，et al.HLA-B 13：01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemicsymptoms in Chinese Han population[J].Pharmacogenomics，2014，15(11)：1461-1469.
[10]徐永豪，苏英，赵杰，等.醋甲唑胺致HLA-B5901阳性患者中毒性表皮坏死松解症一例[J].中华皮肤科杂志，2015，48(2)：131-133.
[11] Tas S，Simonart T.Management of drug rash with eosinophilia and systemic symptoms(DRESS syndrome)：an update[J].Dermatology，2003，206(4)：353-356.
[12]凌磊，皮肖冰，李潔华，等.75例重症药疹回顾性分析[J].国际医药卫生导报，2016，22(21)：3227-3230.
[13] Zhu Q Y，Ma L，Luo X Q，et al.Toxic epidermal necrolysis：performance of SCORTEN and the score-based comparison of the efficacy of cortieosteroid therapy and intravenous immunoglobulin combined therapy in China[J].Burn Care Res，2012，33(6)：e295-e308.
[14] Bachot N，Roujeau J C.Intravenous immunoglobulins in the treatment of severe drug eruptions[J].Curt Opin Allergy Clin Immunol，2003，3(4)：269-274.
[15]李铁男，孙晓杰，陈晴燕，等.血浆置换疗法治疗重症大疱性皮肤病及药疹47例疗效观察[J].中华皮肤科杂志，2010，43(8)：565-567.
[16]陈玲玲，路丹丹，施辛，等.肿瘤坏死因子α拮抗剂治疗一例伴嗜酸性粒细胞增多和系统症状药疹的临床观察[J].中华皮肤科杂志，2013，46(9)：621-625.
(收稿日期：2017-08-14), 百拇医药(梅永红 高锦团 郭燕妮)
[6] Ozeki T，Mushiroda T，Yowang A，et al.Genome-wide assoclarion study identifies HLA—A*3 101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population[J].Hum Mol Genet，20l1，20 (5)：1034-1041.
[7] Wu X T，Hu F Y，An D M，et al.Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA—B*1502 allele among patients in central China[J].Epilepsy Behav，2010，19(3)：405-408.
[8] Jarjour S，Barrete M，Normand V，et al.Genetic markers associated with cutaneous adverse drug reactions to allopurinol：a systematic review[J].Pharmacogenomics，2015，16 (7)：755-767.
[9] Yang F，Gu B，Zhang L，et al.HLA-B 13：01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemicsymptoms in Chinese Han population[J].Pharmacogenomics，2014，15(11)：1461-1469.
[10]徐永豪，苏英，赵杰，等.醋甲唑胺致HLA-B5901阳性患者中毒性表皮坏死松解症一例[J].中华皮肤科杂志，2015，48(2)：131-133.
[11] Tas S，Simonart T.Management of drug rash with eosinophilia and systemic symptoms(DRESS syndrome)：an update[J].Dermatology，2003，206(4)：353-356.
[12]凌磊，皮肖冰，李潔华，等.75例重症药疹回顾性分析[J].国际医药卫生导报，2016，22(21)：3227-3230.
[13] Zhu Q Y，Ma L，Luo X Q，et al.Toxic epidermal necrolysis：performance of SCORTEN and the score-based comparison of the efficacy of cortieosteroid therapy and intravenous immunoglobulin combined therapy in China[J].Burn Care Res，2012，33(6)：e295-e308.
[14] Bachot N，Roujeau J C.Intravenous immunoglobulins in the treatment of severe drug eruptions[J].Curt Opin Allergy Clin Immunol，2003，3(4)：269-274.
[15]李铁男，孙晓杰，陈晴燕，等.血浆置换疗法治疗重症大疱性皮肤病及药疹47例疗效观察[J].中华皮肤科杂志，2010，43(8)：565-567.
[16]陈玲玲，路丹丹，施辛，等.肿瘤坏死因子α拮抗剂治疗一例伴嗜酸性粒细胞增多和系统症状药疹的临床观察[J].中华皮肤科杂志，2013，46(9)：621-625.
(收稿日期：2017-08-14), 百拇医药(梅永红 高锦团 郭燕妮)